COVID-19 Results Briefing Bangladesh February 18, 2022 ...

Bangladesh

COVID-19 Results BriefingBangladeshFebruary 18, 2022This document contains summary information on the latest projections from the IHME model on COVID-19in Bangladesh. The model was run on February 17, 2022, with data through February 14, 2022.

Current situation• Daily infections in the last week decreased to 627,000 per day on average compared to 899,000 the week

before (Figure 1.1). Daily hospital census in the last week (through February 14) decreased to 19,000per day on average compared to 27,000 the week before.

• Daily reported cases in the last week decreased to 6,400 per day on average compared to 10,000 theweek before (Figure 2.1).

• Reported deaths due to COVID-19 in the last week increased to 38 per day on average compared to 33the week before (Figure 3.1).

• Total deaths due to COVID-19 in the last week increased to 380 per day on average compared to 340the week before (Figure 3.1). This makes COVID-19 the number 2 cause of death in Bangladesh thisweek (Table 1). Estimated total daily deaths due to COVID-19 in the past week were 10.2 times largerthan the reported number of deaths.

• The daily rate of reported deaths due to COVID-19 is greater than 4 per million in no countries (Figure4.1).

• The daily rate of total deaths due to COVID-19 is greater than 4 per million in no countries (Figure4.2).

• We estimate that 84% of people in Bangladesh have been infected at least once as of February 14(Figure 6.1). Effective R, computed using cases, hospitalizations, and deaths, is greater than 1 in fivecountries. Effective R in Bangladesh was 0.7 on February 3 (Figure 7.1).

• The infection-detection rate in Bangladesh was close to 0% on February 14 (Figure 8.1).• Based on the GISAID and various national databases, combined with our variant spread model, we

estimate the current prevalence of variants of concern (Figures 9.1-9.5). We estimate that the Alphavariant is circulating in five countries, that the Beta variant is circulating in two countries, that theDelta variant is circulating in eight countries, that the Gamma variant is circulating in four countries,and that the Omicron variant is circulating in eight countries.

Trends in drivers of transmission• Mobility last week was 30% higher than the pre-COVID-19 baseline (Figure 11.1). Mobility was lower

than 30% of baseline in one country and 0 subnational locations in the region.• As of February 14, in the COVID-19 Trends and Impact Survey, 53% of people self-report that they

always wore a mask when leaving their home compared to 53% last week (Figure 13.1).• There were 25 diagnostic tests per 100,000 people on February 14 (Figure 15.1).• As of February 14, five countries have reached 70% or more of the population who have received at

least one vaccine dose, and two countries have reached 70% or more of the population who are fullyvaccinated (Figure 17.1). 63% of people in Bangladesh have received at least one vaccine dose, and 42%are fully vaccinated.

• In Bangladesh, 90.5% of the population that is 12 years and older say they would accept, or wouldprobably accept, a vaccine for COVID-19. Note that vaccine acceptance is calculated using survey datafrom the 18+ population. This is down by 2.2 percentage points from last week. The proportion of thepopulation who are open to receiving a COVID-19 vaccine ranges from 66% in Timor-Leste to 100% inBhutan (Figure 19.1).

• In our current reference scenario, we expect that 111.2 million people will be vaccinated with at leastone dose by June 1 (Figure 20.1). We expect that 66% of the population will be fully vaccinated byJune 1.

covid19.healthdata.org Institute for Health Metrics and Evaluation

Bangladesh

Projections and scenariosWe produce three scenarios when projecting COVID-19. The reference scenario is our forecast of what wethink is most likely to happen:

• Vaccines are distributed at the expected pace. Brand- and variant-specific vaccine efficacy is updatedusing the latest available information from peer-reviewed publications and other reports.

• Future mask use is the mean of mask use over the last seven days.• Mobility increases as vaccine coverage increases.• Omicron variant spreads according to our flight and local spread model.• 80% of those who have had two doses of vaccine (or one dose for Johnson & Johnson) receive a third

dose at six months after their second dose.

The 80% mask use scenario makes all the same assumptions as the reference scenario but assumes alllocations reach 80% mask use within seven days. If a location currently has higher than 80% use, mask useremains at the current level.

The third dose scenario is the same as the reference scenario but assumes that 100% of those who havereceived two doses of vaccine will get a third dose at six months.

ProjectionsInfections

• Daily estimated infections in the reference scenario will decline to 49,060 by June 1, 2022 (Figure22.1).

• Daily estimated infections in the 80% mask use scenario will decline to 24,390 by June 1, 2022(Figure 22.1).

• Daily estimated infections in the third dose scenario will decline to 26,960 by June 1, 2022 (Figure22.1).

Cases

• Daily estimated cases in the reference scenario will decline to 320 by June 1, 2022 (Figure 22.2).• Daily estimated cases in the 80% mask use scenario will decline to 160 by June 1, 2022 (Figure

22.2).• Daily estimated cases in the third dose scenario will decline to 190 by June 1, 2022 (Figure 22.2).

Hospitalizations

• Daily hospital census in the reference scenario will decline to 910 by June 1, 2022 (Figure 22.3).• Daily hospital census in the 80% mask use scenario will decline to 450 by June 1, 2022 (Figure 22.3).• Daily hospital census in the third dose scenario will decline to 440 by June 1, 2022 (Figure 22.3).

Deaths

• In our reference scenario, our model projects 30,000 cumulative reported deaths due to COVID-19on June 1. This represents 880 additional deaths from February 14 to June 1. Daily reported COVID-19deaths in the reference scenario will decline to no by June 1, 2022 (Figure 22.4).

• Under our reference scenario, our model projects 304,000 cumulative total deaths due to COVID-19on June 1. This represents 8,900 additional deaths from February 14 to June 1 (Figure 25.2).

• In our 80% mask use scenario, our model projects 30,000 cumulative reported deaths due to COVID-19 on June 1. This represents 750 additional deaths from February 14 to June 1. Daily reportedCOVID-19 deaths in the 80% mask use scenario will decline to no by June 1, 2022 (Figure 22.4).


Bangladesh

• In our third dose scenario, our model projects 30,000 cumulative reported deaths due to COVID-19on June 1. This represents 780 additional deaths from February 14 to June 1. Daily reported COVID-19deaths in the third dose scenario will decline to no by June 1, 2022 (Figure 22.4).

• Figure 23.1 compares our reference scenario forecasts to other publicly archived models. Forecasts arewidely divergent.

• At some point from February through June 1, 7 countries will have high or extreme stress on hospitalbeds (Figure 24.1). At some point from February through June 1, 7 countries will have high or extremestress on intensive care unit (ICU) capacity (Figure 25.1).


Bangladesh

Model updatesNo model updates.


Bangladesh

Figure 1.1: Daily COVID-19 hospital census and estimated infections

0

500,000

1,000,000

1,500,000

2,000,000

Jan

20

Mar

20

May

20

Jul 2

0

Sep 2

0

Nov 2

0

Jan

21

Mar

21

May

21

Jul 2

1

Sep 2

1

Nov 2

1

Jan

22

Mar

22

Num

ber

of p

eopl

e

Daily estimated infections Daily hospital census

Figure 2.1: Reported daily COVID-19 cases, moving average

0

5,000

10,000

15,000

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Cou

nt

Daily cases


Bangladesh

Table 1: Ranking of total deaths due to COVID-19 among the leading causes of mortality thisweek, assuming uniform deaths of non-COVID causes throughout the year

Cause name Weekly deaths RankingStroke 3,054 1COVID-19 2,689 2Ischemic heart disease 2,519 3Chronic obstructive pulmonary disease 1,070 4Neonatal disorders 773 5Lower respiratory infections 717 6Diabetes mellitus 636 7Diarrheal diseases 633 8Tuberculosis 559 9Cirrhosis and other chronic liver diseases 503 10

Figure 3.1: Smoothed trend estimate of reported daily COVID-19 deaths (blue) and totaldaily deaths due to COVID-19 (orange)

0

1,000

2,000

Jan

20

Mar

20

May

20

Jul 2

0

Sep 2

0

Nov 2

0

Jan

21

Mar

21

May

21

Jul 2

1

Sep 2

1

Nov 2

1

Jan

22

Mar

22

Dai

ly d

eath

s


Bangladesh

Daily COVID-19 death rate per 1 million on February 14, 2022

Figure 4.1: Daily reported COVID-19 death rate per 1 million

<1

1 to 1.9

2 to 2.9

3 to 3.9

4 to 4.9

5 to 5.9

6 to 6.9

7 to 7.9

>=8

Figure 4.2: Daily total COVID-19 death rate per 1 million

<1

1 to 1.9

2 to 2.9

3 to 3.9

4 to 4.9

5 to 5.9

6 to 6.9

7 to 7.9

>=8


Bangladesh

Cumulative COVID-19 deaths per 100,000 on February 14, 2022

Figure 5.1: Reported cumulative COVID-19 deaths per 100,000

<50

50 to 99

100 to 149

150 to 199

200 to 249

250 to 299

300 to 349

350 to 399

>=400

Figure 5.2: Total cumulative COVID-19 deaths per 100,000

<50

50 to 99

100 to 149

150 to 199

200 to 249

250 to 299

300 to 349

350 to 399

>=400


Bangladesh

Figure 6.1: Estimated percent of the population infected with COVID-19 on February 14,2022

<10

10−19.9

20−29.9

30−39.9

40−49.9

50−59.9

60−69.9

70−79.9

80−84.9

85−89.9

90−94.9

>=95

Figure 7.1: Mean effective R on February 3, 2022. Effective R less than 1 means that transmissionshould decline, all other things being held the same. The estimate of effective R is based on the combinedanalysis of deaths, case reporting, and hospitalizations where available. Current reported cases reflectinfections 11-13 days prior, so estimates of effective R can only be made for the recent past.

<0.51

0.51−0.62

0.63−0.74

0.75−0.87

0.88−0.99

1−1.07

1.08−1.16

1.17−1.24

1.25−1.32

>=1.33


Bangladesh

Figure 8.1: Percent of estimated COVID-19 infections detected. This is estimated as the ratioof reported daily COVID-19 cases to estimated daily COVID-19 infections based on the SEIR diseasetransmission model. Due to measurement errors in cases and testing rates, the infection-detection rate canexceed 100% at particular points in time.

0%

25%

50%

75%

100%

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Per

cent

of e

stim

ated

infe

ctio

ns d

etec

ted

Indonesia Myanmar Thailand Bangladesh India


Bangladesh

Estimated percent of circulating SARS-CoV-2 for primary variant families on February 14, 2022

Figure 9.1: Estimated percent of new infections that are Alpha variant

0%

1−9%

10−24%

25−49%

50−74%

75−89%

90−100%

Figure 9.2: Estimated percent of new infections that are Beta variant

0%

1−9%

10−24%

25−49%

50−74%

75−89%

90−100%


Bangladesh

Figure 9.3: Estimated percent of new infections that are Delta variant

0%

1−9%

10−24%

25−49%

50−74%

75−89%

90−100%

Figure 9.4: Estimated percent of new infections that are Gamma variant

0%

1−9%

10−24%

25−49%

50−74%

75−89%

90−100%


Bangladesh

Figure 9.5: Estimated percent of new infections that are Omicron variant

0%

1−9%

10−24%

25−49%

50−74%

75−89%

90−100%


Bangladesh

Figure 10.1: Infection-fatality rate on February 14, 2022. This is estimated as the ratio of COVID-19deaths to estimated daily COVID-19 infections.

< 0.2%

0.2% to 0.39%

0.4% to 0.59%

0.6% to 0.79%

0.8% to 0.99%

> 1%


Bangladesh

Critical driversTable 2: Current mandate implementation

Prim

ary

scho

ol c

losu

re

Sec

onda

ry s

choo

l clo

sure

Hig

her

scho

ol c

losu

re

Ent

ry r

estr

ictio

ns fo

r so

me

non−

resi

dent

s

Ent

ry r

estr

ictio

ns fo

r al

l non

−re

side

nts

Indi

vidu

al m

ovem

ents

res

tric

ted

Cur

few

for

busi

ness

es

Indi

vidu

al c

urfe

w

Gat

herin

g lim

it: 6

indo

or, 1

0 ou

tdoo

r

Gat

herin

g lim

it: 1

0 in

door

, 25

outd

oor

Gat

herin

g lim

it: 2

5 in

door

, 50

outd

oor

Gat

herin

g lim

it: 5

0 in

door

, 100

out

door

Gat

herin

g lim

it: 1

00 in

door

, 250

out

door

Res

taur

ants

clo

sed

Bar

s cl

osed

Res

taur

ants

/ ba

rs c

lose

d

Res

taur

ants

/ ba

rs c

urbs

ide

only

Gym

s, p

ools

, oth

er le

isur

e cl

osed

Non

−es

sent

ial r

etai

l clo

sed

Non

−es

sent

ial r

etai

l cur

bsid

e on

ly

Non

−es

sent

ial w

orkp

lace

s cl

osed

Sta

y ho

me

orde

r

Sta

y ho

me

fine

Mas

k m

anda

te

Mas

k m

anda

te fi

ne

Timor−Leste

Thailand

Sri Lanka

Nepal

Myanmar

Maldives

Indonesia

India

Bhutan

Bangladesh

Mandate in placeMandate in place(imposed this week)Mandate in place(updated from previous reporting)

Mandate imposed in some subnational locationsMandate imposed in some subnational locations(imposed this week)Mandate imposed in some subnational locations(updated from previous reporting)

No mandateNo mandate(lifted this week)No mandate(updated from previous reporting)

*Not all locations are measured at the subnational level.


Bangladesh

Figure 11.1: Trend in mobility as measured through smartphone app use, compared to January2020 baseline

−50

0

50

Dec 1

9

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Per

cent

red

uctio

n fr

om a

vera

ge m

obili

ty



Bangladesh

Figure 12.1: Mobility level as measured through smartphone app use, compared to January2020 baseline (percent) on February 14, 2022

=<−50

−49 to −45

−44 to −40

−39 to −35

−34 to −30

−29 to −25

−24 to −20

−19 to −15

−14 to −10

>−10


Bangladesh

Figure 13.1: Trend in the proportion of the population reporting always wearing a mask whenleaving home

0

25

50

75

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Per

cent

of p

opul

atio

n


Figure 14.1: Proportion of the population reporting always wearing a mask when leaving homeon February 14, 2022

0%

<10%

10−20%

20−30%

30−40%

40−50%

50−60%

60−70%

70−80%

80−90%

90−100%


Bangladesh

Figure 15.1: Trend in COVID-19 diagnostic tests per 100,000 people

0

50

100

150

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Test

per

100

,000

pop

ulat

ion


Figure 16.1: COVID-19 diagnostic tests per 100,000 people on February 14, 2022

<5

5 to 9.9

10 to 24.9

25 to 49

50 to 149

150 to 249

250 to 349

350 to 449

450 to 499

>=500


Bangladesh

Table 3: Estimates of vaccine effectiveness for specific vaccines used in the model at preventingsevere disease and infection. We use data from clinical trials directly, where available, and make estimatesotherwise. More information can be found on our website.


http://www.healthdata.org/node/8584

Bangladesh

Percent of the population having received at least one dose (17.1) and fully vaccinated against SARS-CoV-2(17.2) by February 14, 2022

Figure 17.1: Percent of the population having received one dose of a COVID-19 vaccine

0%

<10%

10−20%

20−30%

30−40%

40−50%

50−60%

60−70%

70−80%

80−90%

90−100%

Figure 17.2: Percent of the population fully vaccinated against SARS-CoV-2

0%

<10%

10−20%

20−30%

30−40%

40−50%

50−60%

60−70%

70−80%

80−90%

90−100%


Bangladesh

Figure 18.1: Trend in the estimated proportion of the population that is 12 years and olderthat has been vaccinated or would probably or definitely receive the COVID-19 vaccine ifavailable. Note that vaccine acceptance is calculated using survey data from the 18+ population.

0

25

50

75

100

Dec 2

0

Jan

21

Feb

21

Mar

21

Apr 2

1

May

21

Jun

21

Jul 2

1

Aug 2

1

Sep 2

1

Oct 21

Nov 2

1

Dec 2

1

Jan

22

Feb

22

Per

cent

of p

opul

atio

n


Figure 19.1: Estimated proportion of the population that is 12 years and older that has beenvaccinated or would probably or definitely receive the COVID-19 vaccine if available. Note thatvaccine acceptance is calculated using survey data from the 18+ population.

0%

<10%

10−20%

20−30%

30−40%

40−50%

50−60%

60−70%

70−80%

80−90%

90−100%


Bangladesh

Figure 20.1: Percent of people who receive at least one dose of a COVID-19 vaccine and thosewho are fully vaccinated

0%

10%

20%

30%

40%

50%

60%

70%

Dec 2

0

Jan

21

Feb

21

Mar

21

Apr 2

1

May

21

Jun

21

Jul 2

1

Aug 2

1

Sep 2

1

Oct 21

Nov 2

1

Dec 2

1

Jan

22

Feb

22

Mar

22

Apr 2

2

May

22

Jun

22

Per

cent

of p

opul

atio

n

At least one dose Fully vaccinated

Figure 21.1: Percent of people who are immune to Delta or Omicron. Immunity is based onprotection due to prior vaccination and infection(s). Moreover, variant-specific immunity isalso based on variant-variant specific protection.

20%

30%

40%

50%

60%

70%

80%

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Apr 2

2

Jun

22

Per

cent

of p

opul

atio

n

Delta Omicron


Bangladesh

Projections and scenariosFigure 22.1: Daily COVID-19 infections until June 01, 2022 for three scenarios

0

500,000

1,000,000

1,500,000

2,000,000

0

500

1000

1500

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Apr 2

2

Jun

22

Dai

ly e

stim

ated

infe

ctio

nsD

aily estimated infections per 100,000

Reference

80% mask use

Third dose

Figure 22.2: Daily COVID-19 reported cases until June 01, 2022 for three scenarios

0

5,000

10,000

15,000

0.0

2.5

5.0

7.5

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Apr 2

2

Jun

22

Dai

ly c

ases

Daily cases per 100,000

Reference

80% mask use

Third dose


Bangladesh

Figure 22.3: Daily COVID-19 hospital census until June 01, 2022 for three scenarios

0

30,000

60,000

90,000

0

20

40

60

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Apr 2

2

Jun

22

Hos

pita

l cen

sus

Hospital census per 100,000 population

80% mask use

Reference

Third dose


Bangladesh

Figure 22.4: Reported daily COVID-19 deaths per 100,000

0

50

100

150

200

250

0.00

0.05

0.10

0.15

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Apr 2

2

Jun

22

Dai

ly d

eath

sD

aily deaths per 100,000

Reference

80% mask use

Third dose


Bangladesh

Figure 22.5: Total daily COVID-19 deaths per 100,000

0

1,000

2,000

0.0

0.5

1.0

1.5

Feb

20

Apr 2

0

Jun

20

Aug 2

0

Oct 20

Dec 2

0

Feb

21

Apr 2

1

Jun

21

Aug 2

1

Oct 21

Dec 2

1

Feb

22

Apr 2

2

Jun

22

Dai

ly d

eath

sD

aily deaths per 100,000

Reference

80% mask use

Third dose


Bangladesh

Figure 23.1: Comparison of reference model projections with other COVID modeling groups.For this comparison, we are including projections of daily COVID-19 deaths from other modeling groups whenavailable, last model update in brackets: Delphi from the Massachusetts Institute of Technology (Delphi)[February 17, 2022], Imperial College London (Imperial) [January 2, 2022], the SI-KJalpha model from theUniversity of Southern California (SIKJalpha) [February 17, 2022]. Daily deaths from other modeling groupsare smoothed to remove inconsistencies with rounding. Regional values are aggregates from available locationsin that region.

0

10

20

30

Mar

22

Apr 2

2

May

22

Jun

22

Date

Dai

ly d

eath

s

Models

IHME (reported deaths)

Delphi

Imperial

SIKJalpha


https://www.covidanalytics.io/home

https://www.covidsim.org

https://github.com/scc-usc/ReCOVER-COVID-19

Bangladesh

Figure 24.1: The estimated inpatient hospital usage is shown over time. The percent of hospitalbeds occupied by COVID-19 patients is color-coded based on observed quantiles of the maximum proportionof beds occupied by COVID-19 patients. Less than 5% is considered low stress, 5-9% is considered moderatestress, 10-19% is considered high stress, and 20% or greater is considered extreme stress.

Timor−Leste

Thailand

Sri Lanka

Nepal

Myanmar

Maldives

Indonesia

India

Bangladesh

Mar

20

May

20

Jul 2

0

Sep 2

0

Nov 2

0

Jan

21

Mar

21

May

21

Jul 2

1

Sep 2

1

Nov 2

1

Jan

22

Mar

22

May

22

Jul 2

2

Stress level

Low

Moderate

High

Extreme

All hospital beds


Bangladesh

Figure 25.1: The estimated intensive care unit (ICU) usage is shown over time. The percentof ICU beds occupied by COVID-19 patients is color-coded based on observed quantiles of the maximumproportion of ICU beds occupied by COVID-19 patients. Less than 10% is considered low stress, 10-29% isconsidered moderate stress, 30-59% is considered high stress, and 60% or greater is considered extreme stress.

Timor−Leste

Thailand

Sri Lanka

Nepal

Myanmar

Maldives

Indonesia

India

Bangladesh

Mar

20

May

20

Jul 2

0

Sep 2

0

Nov 2

0

Jan

21

Mar

21

May

21

Jul 2

1

Sep 2

1

Nov 2

1

Jan

22

Mar

22

May

22

Jul 2

2

Stress level

Low

Moderate

High

Extreme

Intensive care unit beds


Bangladesh

More informationData sources:

Mask use and vaccine confidence data are from the The Delphi Group at Carnegie Mellon University andUniversity of Maryland COVID-19 Trends and Impact Surveys, in partnership with Facebook. Mask use dataare also from Premise, the Kaiser Family Foundation, and the YouGov COVID-19 Behaviour Tracker survey.

Genetic sequence and metadata are primarily from the GISAID Initiative. Further details available on theCOVID-19 model FAQ page.

A note of thanks:

We wish to warmly acknowledge the support of these and others who have made our COVID-19 estimationefforts possible.

More information:

For all COVID-19 resources at IHME, visit http://www.healthdata.org/covid.

To download our most recent results, visit our Data downloads page.

Questions? Requests? Feedback? Please contact us at https://www.healthdata.org/covid/contact-us.


https://dataforgood.fb.com/tools/symptomsurvey/

https://dataforgood.fb.com/tools/symptomsurvey/

https://www.premise.com/covid-19/

https://today.yougov.com/covid-19

https://www.healthdata.org/covid/faqs/

https://www.healthdata.org/covid/acknowledgements

http://www.healthdata.org/covid

http://www.healthdata.org/covid/data-downloads

https://www.healthdata.org/covid/contact-us

COVID-19 Results Briefing Bangladesh February 18, 2022 ...

Documents

Transcript of COVID-19 Results Briefing Bangladesh February 18, 2022 ...